Benzinga | Oct 8, 2021 07:57AM EDT

Morgan Stanley Maintains Equal-Weight on CME Group, Lowers Price Target to $217

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Equal-Weight and lowers the price target from $229 to $217.